Pelthos Therapeutics Inc.
PTHS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $14 | $0 | $0 | $1 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $8 | $0 | $0 | $0 |
| Inventory | $24 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $1 | $1 | $1 |
| Total Curr. Assets | $49 | $1 | $1 | $1 |
| Property Plant & Equip (Net) | $14 | $0 | $0 | $0 |
| Goodwill | $31 | $0 | $0 | $0 |
| Intangibles | $33 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $0 | $0 | $0 |
| Total NC Assets | $77 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $126 | $1 | $1 | $1 |
| Liabilities | – | – | – | – |
| Payables | $6 | $5 | $3 | $2 |
| Short-Term Debt | $1 | $2 | $3 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $0 | $0 | $0 |
| Other Curr. Liab. | $17 | $0 | $0 | $0 |
| Total Curr. Liab. | $25 | $7 | $5 | $4 |
| LT Debt | $3 | $0 | $0 | $0 |
| Deferred Rev, NC | $2 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $13 | $0 | $0 | $0 |
| Other NC Liab. | $26 | $0 | $0 | $0 |
| Total NC Liab. | $43 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $0 | $0 | $0 |
| Total Liabilities | $68 | $7 | $5 | $4 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$43 | -$27 | -$23 | -$21 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $101 | $20 | $19 | $19 |
| Total Equity | $58 | -$6 | -$4 | -$3 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $126 | $1 | $1 | $1 |
| Net Debt | -$11 | $2 | $2 | $2 |